In type 2 diabetes, ecological and lifecourse factors may interact with the host microbiota to
influence expression of his/her genomes causing perturbation of interconnecting biological …

Simple Summary Metformin, a common anti-diabetic drug, is being explored for its potential
in managing cancer, especially in breast and colorectal cancer. It works by affecting …

Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for
over 50 years. However, the molecular basis of its therapeutic role remained incompletely …

The most widely prescribed oral anti-diabetic agent today in the world today is a member of
the biguanide class of drugs called metformin. Apart from its use in diabetes, it is currently …

Cancer continues to pose a significant global health challenge, as evidenced by the
increasing incidence rates and high mortality rates, despite the advancements made in …

Cancer metabolism is the focus of intense research, which witnesses its key role in human
tumors. Diabetic patients treated with metformin exhibit a reduced incidence of cancer and …

Background Ageing is characterized by a decline in cognitive and bodily functions.
Metformin, the most commonly prescribed antidiabetic agent today, has proved to be able to …

Metformin is a well-known anti-diabetic drug that has been repurposed for several emerging
applications, including as an anti-cancer agent. It boasts the distinct advantages of an …

Metformin has been designated as one of the most crucial first-line therapeutic agents in the
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …

Metformin beneficially impacts several aspects of metabolic syndrome including
dysglycemia, obesity, and liver dysfunction, thus making it a widely used frontline treatment …